Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Nebivolol hydrochloride in β1 Signaling Assays
2026-09-08
Nebivolol hydrochloride provides a precise β1-adrenoceptor antagonist tool for dissecting cardiac signaling while serving as a useful negative comparator in mTOR/TOR discovery workflows. This article combines formulation guidance, receptor-assay design, yeast counter-screening, and troubleshooting for more interpretable cardiovascular pharmacology research.
-
EDC.HCl: Practical In Vitro Coupling Guide
2026-09-07
EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis, bioconjugation, and related laboratory workflows. This guidance is for controlled in vitro use only; the supplied dossier reports no in vivo or clinical data and recommends avoiding long-term storage of prepared solutions.
-
Diphenyleneiodonium Chloride in ROS Assays
2026-09-07
Diphenyleneiodonium chloride is a powerful but nonselective probe for separating redox-enzyme activity from cAMP signaling. This article translates recent iron–ROS–ferroptosis research into practical assay-design decisions, controls, and interpretation strategies.
-
MVC Activates RhoA/ROCK1 to Disrupt Tight Junctions
2026-09-05
The reference study identifies a mechanism by which Minute Virus of Canines (MVC) activates the RhoA/ROCK1/MLC2 axis, remodels tight junctions, and promotes occludin-associated viral entry. Its combination of VP2–ROCK1 interaction mapping, pathway inhibition, permeability analysis, and viral replication readouts provides a mechanistic framework for studying MVC infection in canine cells.
-
GPR35–KLF5 Repair Circuitry in Colitis
2026-09-04
A 2026 Cell Death & Disease study identifies a tryptophan–kynurenine–kynurenic acid sensing mechanism in which GPR35 activates KLF5-dependent epithelial repair through PI3K–AKT–mTOR signaling. The work connects metabolic damage sensing with intestinal epithelial cell proliferation and migration, offering a mechanistic framework for ulcerative colitis research while highlighting important translational limitations.
-
Foretinib: Mapping Growth Arrest vs Cell Death
2026-09-04
Foretinib and GSK1363089 research are examined through a phenotype-first framework that separates tumor cell growth inhibition from cell death. Learn how to integrate kinase potency, motility assays, and metastasis models for more interpretable cancer research.
-
DMG-PEG2000-NH2: From Linker to Assay Design
2026-09-03
DMG-PEG2000-NH2 is an NH2-PEG derivative that connects lipid-based delivery design with rigorous biomolecular assay planning. This article explains how to evaluate its reaction logic, formulation role, controls, and the limits of translating medicinal-chemistry evidence into delivery experiments.
-
Sabutoclax: Measuring Apoptosis Beyond Viability
2026-09-03
Sabutoclax is a pan-Bcl-2 inhibitor whose apparent potency can reflect both growth arrest and cell death. This guide applies a refined response-measurement framework to apoptosis induction in cancer cells, helping researchers design more informative assays and interpret preclinical data.
-
Promethazine HCl Workflows for Macrophage Research
2026-09-02
Promethazine HCl supports controlled studies of H1 receptor antagonism, macrophage ROS, autophagy, and host-directed antibacterial activity. This practical guide connects assay design with concentration planning, mechanistic controls, and troubleshooting while separating evidence from workflow recommendations.
-
PreScission Protease (PSP): Practical Tag Cleavage
2026-09-02
PreScission Protease (PSP) provides sequence-specific removal of compatible fusion tags from recombinant proteins through HRV 3C protease cleavage at the Gln-Gly junction. It is suited to controlled protein purification workflows operated at low temperature, but should not be treated as a universal protease for constructs lacking the recognition site or for conditions that have not been validated.
-
Inside-Out Design of Ternary RNA Nanoparticles
2026-09-01
This ACS Nano study shows that polyanion chemistry, PEG architecture, hydrophobicity, and charge density jointly determine the structure and biological performance of ternary nanoparticles for self-amplifying RNA delivery. By combining high-throughput stability assays, neutron scattering, spectroscopy, cell studies, and molecular dynamics, the authors identify a pH-responsive formulation that balances extracellular stability with intracellular RNA release.
-
H 89 2HCl for Reproducible PKA Assays
2026-09-01
A scenario-based guide to using H 89 2HCl (SKU B2190) in cell viability, proliferation, and cytotoxicity workflows. It explains solvent handling, concentration selection, pathway-specific controls, off-target interpretation, and practical criteria for choosing a reliable PKA inhibitor.
-
Azumiobodo hoyamushi Drug Efficacy in Ascidians
2026-08-31
Park and colleagues combined an in vitro concentration-response screen with an in vivo infection model to evaluate control strategies for Azumiobodo hoyamushi, the protozoan associated with soft tunic syndrome in cultured ascidians. The study identified formalin and chlorine dioxide as the most promising agents for reducing parasite burden in infected Halocynthia roretzi, while Sulfamonomethoxine showed comparatively weak direct antiparasitic activity under the tested conditions.
-
Fulvestrant: ER Causal Inference in Cancer Models
2026-08-31
Fulvestrant (ICI 182,780) is more than an estrogen antagonist: it is a practical probe for separating ER-dependent signaling, MDM2 protein degradation, and downstream cell fate. This article connects breast cancer assays with a mechanistic immune study while defining the limits of that cross-domain interpretation.
-
Fasudil (HA-1077) HCl: ROCK Inhibitor Workflows
2026-08-30
Explore practical Fasudil (HA-1077) HCl workflows for Rho/ROCK pathway inhibition, cancer-cell motility, proliferation, and apoptosis assays. The guide also shows how the compound can serve as a hypothesis-testing perturbation in oxidative-stress lens models inspired by recent Hippo-pathway research.